Inhaled corticosteroids in COPD and the risk of serious pneumonia

BACKGROUND: Inhaled corticosteroids (ICS) are known to increase the risk of pneumonia in patients with chronic obstructive pulmonary disease (COPD). It is unclear whether the risk of pneumonia varies for different inhaled agents, particularly fluticasone and budesonide, and increases with the dose a...

Descripción completa

Detalles Bibliográficos
Autores principales: Suissa, Samy, Patenaude, Valérie, Lapi, Francesco, Ernst, Pierre
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2013
Materias:
Epidemiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3812880/
https://www.ncbi.nlm.nih.gov/pubmed/24130228
http://dx.doi.org/10.1136/thoraxjnl-2012-202872

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3812880/
https://www.ncbi.nlm.nih.gov/pubmed/24130228
http://dx.doi.org/10.1136/thoraxjnl-2012-202872

Ejemplares similares